| Apalutamide investigated in trials for …INVESTIGATED_IN_TRIALSderived14 of 14 |
|---|
| → investigated in trials for | Malignant Prostate Neoplasmcancer 60 trials (27 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Prostate Neoplasm | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prostate Neoplasmsubtype 23 trials (13 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Prostate Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prostate Adenocarcinoma 16 trials (11 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Prostate Adenocarcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Castration-Resistant Prostate Carcinoma 13 trials (8 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Castration-Resistant Prostate Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prostate Carcinoma 9 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Prostate Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Castration-Sensitive Prostate Carcinoma 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Castration-Sensitive Prostate Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic and Lymphoid Cell Neoplasm 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neoplasmcancer_family 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oligometastatic Prostate Carcinoma 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prostate Adenocarcinoma without Neuroendocrine Differentiation 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Prostate Adenocarcinoma without Neuroendocrine Differentiation | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Salivary Gland Neoplasmcancer_family 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Small Cell Neuroendocrine Carcinoma 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |